InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Adimab, LLC. Officer active across 2 companies, notably Adagio Therapeutics, Inc.. Aggregated, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €18.2m. History available since 19 January 2024. The latest transaction was disclosed on 19 January 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Adimab, LLC is a declarant linked to Adagio Therapeutics, Inc. and Invivyd, Inc. Across 4 filings, the sampled recent filings run from 2021-08-12 to 2024-01-22, with 0 in purchases and 18154003 EUR in sales; the most recent concerns Invivyd, Inc. and a sale of 18154002.69578845 EUR.